Breast Tissue Markets and Breast Localization Wires Market Report Suite | United States | 2016-2022 | MedSuite

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Pages: 42
  • Published Date: 11/1/2016
  • Type: MedSuite

Product Description

Major Segments Covered in the Breast Tissue Markers and Breast Localization Wires Market Report Suite

In 2015, wire-guided breast localization was the most commonly used method for breast lesion localization in the United States. Though widely used, wire localization is associated with several drawbacks including scheduling difficulties and high re-excision rates. The drawbacks of wire localization have given rise to the development of alternative localization methods. Several leading alternative methods for breast lesion localization include the electromagnetic reflector method (SAVI SCOUT®, Cianna Medical), magnetic tracer localization method (Sentimag®, Endomag), radioactive seed localization (RSL) method and intraoperative ultrasound (IOUS) method. The use of alternative localization methods is expected to increase over the forecast period, cannibalizing unit sales of the breast localization wire market.

The full report suite on this market includes breast tissue markers and breast localization wires.

While this report suite contains all U.S. breast tissue markers and breast localization wire device data, each of the markets are also available as standalone MedCore reports. This allows you to get access to only the market research that you need. You can view all these included reports and segmentation here:

Breast Tissue Marker and Breast Localization Wire Market Trends

The number of new cases of invasive and in situ female breast cancer in the U.S. is expected to reach about 441,000 by 2030. Growth will be driven by the aging U.S. population, increased mammogram procedure volume and improvement in mammogram quality. The rising volume of diagnoses will drive an increase in the number of patients requiring treatment, applying upward pressure to breast tissue marker unit sales and limiting the decline in breast localization wire unit sales over the forecast period.

This report includes an analysis of other factors and trends that have positively and negatively impacted the market.

Breast Tissue Marker and Breast Localization Wire Market Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2022, and Historical Data to 2012
  • Market Drivers & Limiters for Each Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Breast Tissue Marker and Breast Localization Wire Companies Analyzed

Mammotome held the leading position in the U.S. breast tissue marker market in 2015. The increasing use of breast tissue markers for axillary node marking is expected to drive sales for Mammotome over the forecast period. Mammotome acquired the HydroMARK® breast biopsy marker portfolio from Biopsy Sciences in 2014. Hologic was the second leading competitor in the U.S. market for breast tissue markers in 2015. Hologic competes on price, as such, its breast tissue markers are often sold below the ASP of the total breast marker market. The company has lost share in recent years to C. R. Bard and Mammotome.

C. R. Bard held a commanding lead in the U.S. breast localization wire market in 2015. The company is expected to leverage its extensive breast biopsy portfolio and strong relationships with breast centers across the U.S. to maintain the leading position in the breast localization wire market over the forecast period.

Other companies researched in this report includes Argon Medical, Somatex, Cook Medical, Becton Dickinson and more.

History of Our Breast Tissue Marker and Breast Localization Wire Market Research

We’ve been doing market research for medical devices for over a decade. We have built relationships with the top competitors in the breast tissue marker and breast localization wire market so that we can gather proprietary information in confidence to assure more accurate research – that our partners and clients then benefit from.

Because we’re a third party researcher, we have the ability to reach well into the top breast tissue marker and localization wire companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that’s incredibly accurate.

Our clients have used our market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.

 

 

FREE Sample Report

The "US Market Report for Breast Tissue Markers and Breast Localization Wires 2016 - MedSuite" includes analysis on the following companies currently active in this market:MammotomeHologicC.R. BardSomatexOthers Include: Argon Medical, Becton Dickinson, Mermaid Medical, Scion Medical Technologies, etc.*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Growth will be driven by the aging U.S. population, increased mammogram procedure volume and improvement in mammogram quality. The rising volume of diagnoses will drive an increase in the number of patients requiring treatment, applying upward pressure to breast tissue marker unit sales and limiting the decline in breast localization wire unit sales over the forecast period.

  • 2016
  • 2012-2022
  • United States
  • 11/1/2016
  • 42
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library